105
MENDONCA S.C., RUSSELL D.G. & COUTINHO S.G. (1991) Analysis of the
human T cell responsiveness to purified antigens of Leishmania:
lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Clin.Exp.Immunol. 83,
472-478.
MOSSALAYI M.D., AROCK M., MAZIER D., VINCENDEAU P. & VOULDOUKIS
I. (1999) The human immune response during cutaneous leishmaniasis: NO
problem. Parasitol.Today 15, 342-345.
MOUGNEAU E., ALTARE F., WAKIL A.E., ZHENG S., COPPOLA T., WANG Z.E.,
WALDMANN R., LOCKSLEY R.M. & GLAICHENHAUS N. (1995)
Expression cloning of a protective Leishmania antigen. Science 268, 563-566.
MURRAY H.W., BERMAN J.D., DAVIES C.R. & SARAVIA N.G. (2005) Advances
in leishmaniasis. Lancet 366, 1561-1577.
MURRAY H.W., LU C.M., MAUZE S., FREEMAN S., MOREIRA A.L., KAPLAN G.
& COFFMAN R.L. (2002) Interleukin-10 (IL-10) in experimental visceral
leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect.Immun.
70, 6284-6293.
NASCIMENTO M.D., COSTA J.M., FIORI B.I., VIANA G.M., FILHO M.S., ALVIM
A.C., BASTOS O.C., NAKATANI M., REED S., BADARO R., DA SILVA
A.R. & BURATTINI M.N. (1996) [The epidemiological determinant aspects in
the maintenance of visceral leishmaniasis in the state of Maranhao, Brazil].
Rev.Soc.Bras.Med.Trop. 29, 233-240.
NYLEN S., MORTBERG U., KOVALENKO D., SATTI I., ENGSTROM K.,
BAKHIET M. & AKUFFO H. (2001) Differential induction of cellular
responses by live and dead Leishmania promastigotes in healthy donors.
Clin.Exp.Immunol. 124, 43-53.
OLIVEIRA C.D., ASSUNCAO R.M., REIS I.A. & PROIETTI F.A. (2001) Spatial
distribution of human and canine visceral leishmaniasis in Belo Horizonte,
Minas Gerais State, Brasil, 1994-1997. Cad.Saude Publica 17, 1231-1239.
PALATNIK DE SOUSA C.B., SANTOS W.R., CASAS C.P., PARAGUAI DE S.E.,
TINOCO L.W., DA SILVA B.P., PALATNIK M. & PARENTE J.P. (2004)
Protective vaccination against murine visceral leishmaniasis using aldehyde-
containing Quillaja saponaria sapogenins. Vaccine 22, 2470-2479.
PALATNIK-DE-SOUSA C.B., GOMES E.M., PARAGUAI-DE-SOUZA E.,
PALATNIK M., LUZ K. & BOROJEVIC R. (1995) Leishmania donovani:
titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and
prognosis of visceral leishmaniasis. Trans.R.Soc.Trop.Med.Hyg. 89, 390-393.
PARAGUAI DE S.E., BERNARDO R.R., PALATNIK M. & PALATNIK DE SOUSA
C.B. (2001) Vaccination of Balb/c mice against experimental visceral
leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani.
Vaccine 19, 3104-3115.
PETERS W. (1993b) Heterogeneity of cutaneous leishmaniasis with emphasis on the
Old World. Schweiz.Med.Wochenschr. 123, 1237-1249.
PORROZZI R., TEVA A., AMARAL V.F., SANTOS DA COSTA M.V. &
GRIMALDI G., Jr. (2004) Cross-immunity experiments between different
species or strains of Leishmania in rhesus macaques (Macaca mulatta).
Am.J.Trop.Med.Hyg. 71, 297-305.